Skip to main content
SpringerLink
Log in

Role of protein kinases in antitumor drug resistance

  • First Workshop of CSG-CR
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Summary

The activity of several proteins involved in the development of antitumor drug resistance is regulated by protein phosphorylation. These proteins include the mdr-1-encoded P-glycoprotein (Pgp) and topoisomerase II (topo II). The corresponding evidence is reviewed and attempts to modulate multidrug resistance (MDR) by protein kinase C inhibitors are described. The expression of several proteins which are essential in drug resistance is regulated at the transcriptional level, involving protein phosphorylation by members of the protein kinase C (PKC) family, casein kinase II (CKII), and others. These proteins include mdr-1-encoded P-glycoprotein, metallothionein, glutathione S-transferase (GST), dTMP synthase, and the proteins Fos and Jun. The corresponding genes are under positive regulation of ras, which in turn requires the activation of a protein kinase cascade for its function. Protein kinases are therefore potentially useful targets in reducing the expression of proteins involved in the development of multifactorial drug resistance caused by the expression of transforming ras-genes. Attempts to inhibit the ras-induced fos expression by an inhibitor of protein kinase C (ilmofosine) are described. Protein kinase inhibitors are also able to synergistically enhance the cytotoxicity of ds-platinum, which is discussed as resulting from a reduction of PKC-dependent fos expression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

CSG-CR :

Cooperative Study Group — Cellular Resistance

References

  1. Ackerman P, Glover CVC, Osheroff N (1988) Phosphorylation of DNA topoisomerase II in vivo and in total homogenates ofDrosophila Kc cells. J Biol Chem 263:12653–12660

    Google Scholar 

  2. Ackermann P, Glover CVC, Osheroff N (1985) Phosphorylation of DNA topoisomerase II by casein kinase II: modulation of eukaryotic topoisomerase II activity in vitro. Proc Natl Acad Sci USA 82:3164–3168

    Google Scholar 

  3. Ahmad S, Glazer RI (1993) Expression of the antisense cDNA for protein kinase Cα attenuates resistance in doxorubicin-resistant MCF-7 breast carcinoma cells. Mol Pharmacol 43:858–862

    Google Scholar 

  4. Baguley BC, Finlay GJ, Ching LM (1992) Resistance mechanisms to topoisomerase poisons: the application of cell culture methods. Oncol Res 4:267–274

    Google Scholar 

  5. Ball RK, Friis RR, Schoenenberger CA, Doppler W, Groner B (1988) Prolactine regulation ofΒ-casein gene expression and of a cytosolic 120-kd protein in a cloned mouse mammary epithelial cell line. EMBO J 7:2089–2095

    Google Scholar 

  6. Blenis J (1993) Signal transduction via the MAP kinases: proceed at your own RSK. Proc Natl Acad Sci USA 90:5889–5892

    Google Scholar 

  7. Chin KV, Ueda K, Pastan I, Gottesman MM (1992) Modulation of activity of the promoter of the human MDR1 gene by ras and p53. Science 255:459–462

    Google Scholar 

  8. Cornwell MM, Smith DE (1993) A signal transduction pathway for activation of the mdrl promoter involves the protooncogene c-raf kinase. J Biol Chem 268:15347–15350

    Google Scholar 

  9. Darkin-Rattray SJ, Ralph RK (1991) Evidence that a protein kinase enhances amsacrme-mediated formation of topoisomerase II-DNA complexes in murine mastocytoma cell nuclei. Biochim Biophys Acta 1088:285–291

    Google Scholar 

  10. Delage S, Chastre E, Empereur S, Wicek D, Veissiére D, Capeau J, Gespach C, Cherqui G (1993) Increased protein kinase Cα expression in human colonic caco-2 cells after insertion of human Ha-ras or polyoma virus middle T oncogenes. Cancer Res 53:2762–2770

    Google Scholar 

  11. DeVore RF, Corbett AH, Osheroff N (1992) Phosphorylation of topoisomerase II by casein kinase II and protein kinase C: effects on enzyme-mediated DNA cleavage/religation and sensitivity to the antineoplastic drugs etoposide and 4′-(9-acridinylamino)methane-sulfon-m-anisidide. Cancer Res 52:2156–2161

    Google Scholar 

  12. Doppler W, Jaggi R, Groner B (1987) Induction of v-mos and Ha-ras oncogene expression in quiescent NIH 3T3 cells causes intracellular alkalinization and cell cycle progression. Gene 54:145–151

    Google Scholar 

  13. Fan D, Fidler IJ, Ward NE, Scid C, Earnest LE, Housey GM, O'Brian CA (1992) Stable expression of a cDNA encoding rat brain protein kinase C-ΒI confers a multidrug-resistant phenotype on rat fibroblasts. Anticancer Res 12:661–668

    Google Scholar 

  14. Fine RL, Patel J, Chabner BA (1988) Phorbol esters induce multidrug resistance in human breast cancer cells. Proc Natl Acad Sci (USA) 85:582–586

    Google Scholar 

  15. Ford JM, Hait WN (1990) Pharmacology of drugs that alter multidrug resistance in cancer. Pharmacol Rev 42:155–199

    Google Scholar 

  16. Funato T, Yoshida E, Jiao L, Tone K, Kashani-Sabet M, Scanion KJ (1992) The utility of an anti-fos ribozyme in reversing cis platin resistance in human carcinomas. Adv Enz Regul 32:195–209

    Google Scholar 

  17. Gottesman MM, Pastan I (1993) Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 62:385–427

    Google Scholar 

  18. Grunicke H, überall F (1992) Protein kinase C modulation. Semin Cancer Biol 3:351–360

    Google Scholar 

  19. Grunicke HH, Hofmann J, Maly K, Oberhuber H, überall F, Egle A, Demuth L (1991) Enhancement of the antiproliferative effect ofcis-diamminedichloroplatinum(II) and other antitumor agents by inhibitors of enzymes involved in growth factor signal transduction. In: Howell SB (ed) Platinum and other metal coordination compounds in cancer chemotherapy. Plenum, New York, pp 161–172

    Google Scholar 

  20. Grunicke HH, Maly K (1993) Role of GTPases and GTPase regulatory proteins in oncogenesis. Crit Rev Oncogenesis 4:389–402

    Google Scholar 

  21. Hamada H, Hagiwara KI, Nakajima T, Tsuruo T (1987) Phosphorylation of the M r 170000 to 180 000 glycoprotein specific to multidrug-resistant tumor cells: effects of verapamil, trifluoperazine, and phorbol esters. Cancer Res 47:2860–2865

    Google Scholar 

  22. Heck MMS, Hittelman WN, Earnshaw WC (1989) In vivo phosphorylation of the 170-kDa form of eukaryotic DNA topoisomerase II. J Biol Chem 264:15161–15164

    Google Scholar 

  23. Hofmann J, Doppier W, Jakob A, Maly K, Posch L, überall F, Grunicke HH (1988) Enhancement of the antiproliferative effect ofcis-diamminedichloroplatinum(II) and nitrogen mustard by inhibitors of protein kinase C. Int J Cancer 42:382–388

    Google Scholar 

  24. Hofmann J, überall F, Posch L, Maly K, Herrmann DBJ, Grunicke H (1989) Synergistic enhancement of the antiproliferative activity ofcis-diamminedichloroplatinum(II) by the ether lipid analogue BM41440, an inhibitor of protein kinase C. Lipids 24:312–317

    Google Scholar 

  25. Hofmann J, überall F, Egle A, Grunicke H (1991) B-859-35, a new drug with anti-tumor activity reverses multi-drug resistance. Int J Cancer 47:870–874

    Google Scholar 

  26. Hofmann J, Wolf A, Spitaler M, Böck G, Drach J, Ludescher C, Grunicke H (1992) Reversal of multidrug resistance by B859-35, a metabolite of B859-35, niguldipine, verapamil and nitrendipine. J Cancer Res Clin Oncol 118:361–366

    Google Scholar 

  27. Isabella P, Caprancio G, Zunino F (1991) The role of topoisomerase II in drug resistance. Life Sci 48:2195–2205

    Google Scholar 

  28. Isonishi S, Andrews PA, Howell SB (1990) Increased sensitivity tocis-diamminedichloroplatinum(II) in human ovarian carcinoma cells in response to treatment with 12-0-tetradecanoylphorbol-13-acetate. J Biol Chem 265:3623–3627

    Google Scholar 

  29. Isonishi S, Horn DK, Thiebaut FB, Mann SC, Andrews PA, Basu A, Lazo JS, Eastman A, Howell SB (1991) Expression of the c-Ha-ras oncogene in mouse NIH 3T3 cells induces resistance to cisplatin. Cancer Res 51:5903–5909

    Google Scholar 

  30. Kimmig A, Gekeler V, Neumann M, Frese G, Handgretinger R, Kardos G, Diddens H, Niethammer D (1990) Susceptibility of multidrug-resistant human leukemia cell lines to human interleukin 2-activated killer cells. Cancer Res 50:6793–6799

    Google Scholar 

  31. Kolch W, Heidecker G, Kochs G, Hummel R, Vahidi H, Mischak H, Finkenzeller G, Marmé D, Rapp UR (1993) Protein kinase Cα activates RAF-1 by direct phosphorylation. Nature 364:249–252

    Google Scholar 

  32. Kroll DJ, Rowe TC (1991) Phosphorylation of DNA topoisomerase II in a human tumor cell line. J Biol Chem 266:7957–7961

    Google Scholar 

  33. Mattern J, Volm M (1993) Multiple-pathway drug resistance (review). Int J Oncol 2:557–561

    Google Scholar 

  34. Meyer T, Regenass U, Fabbro D, Alteri E, Rösel J, Müller M, Carvatti G, Matter A (1989) A derivative of staurosporine (CGP 41251) shows selectivity for PKC inhibition and in vitro antiproliferative as well as in vivo antitumor activity. Int J Cancer 43:851–856

    Google Scholar 

  35. Murren JR, Hait WN (1992) Why haven't we cured multidrug resistant tumors? Oncol Res 4:1–6

    Google Scholar 

  36. Noonan KE, Beck C, Holzmayer TA, Chin JE, Wunder JS, Anrulis IK, Gazdar AF, Willman CL, Griffith B, von Hoff DD, Robinson IB (1990) Quantitative analysis of MDR-1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction. Proc Natl Acad Sci USA 87:7160–7164

    Google Scholar 

  37. Peters GJ, Wets M, Keepers YPAM, Oskam R, Ark-Otte J, Noordhuis P, Smid K, Pinedo HM (1993) Transformation of mouse fibroblasts with the oncogenes H-ras or trk is associated with pronounced changes in drug sensitivity and metabolism. Int J Cancer 54:450–455

    Google Scholar 

  38. Posada J, Vichi P, Tritton TR (1989) Protein kinase C in adriamycin action and resistance in mouse sarcoma 180 cells. Cancer Res 49:6634–6639

    Google Scholar 

  39. Rushmore TH, Pickett CB (1993) Glutathione S-transferases, structure, regulation, and therapeutic implications. J Biol Chem 268:11475–11478

    Google Scholar 

  40. Sahyoun N, Wolf M, Besterman J, Hsieh TS, Sander M, LeVine H, Chang KJ, Cuatrecasas P (1986) Protein kinase C phosphorylates topoisomerase II: topoisomerase II activation and its possible role in phorbol ester-induced differentiation of HL-60 cells. Proc Natl Acad Sci USA 83:1603–1607

    Google Scholar 

  41. Sampson KE, Wolf CL, Abraham I (1993) Staurosporine reduces P-glycoprotein expression and modulates multidrug resistance. Cancer Letters 58:7–14

    Google Scholar 

  42. Sato W, Yusa K, Naito M, Tsuruo T (1990) Staurosporine, a potent inhibitor of C-kinase, enhances drug accumulation in multidrug-resistant cells. Biochem Biophys Res Comm 173:1252–1257

    Google Scholar 

  43. Satoh T, Nakafuku M, Kaziro Y (1992) Function of Ras as a molecular switch in signal transduction. J Biol Chem 267:24149–24152

    Google Scholar 

  44. Scanlon KJ, Kashani-Sabet M, Tone T, Funato T (1991) Cisplatin resistance in human cancer. Pharmacol Ther 52:385–406

    Google Scholar 

  45. Sklar MD (1988) Increased resistance tocis-diamminedichloroplatinum (II) in NIH 3T3 cells transformed by ras oncogene. Cancer Res 48:793–797

    Google Scholar 

  46. Takano H, Kohno K, Matsuo K, Matsuda T, Kuwano M (1992) DNA topoisomerase-targeting antitumor agents and drug resistance. Anticancer Drugs 3:323–330

    Google Scholar 

  47. überall F, Maly K, Egle A, Doppler W, Hofmann J, Grunicke HH (1991) Inhibition of cell proliferation, protein kinase C, and phorbol ester-induced fos expression by the dihydropyridine derivative B859-35. Cancer Res 51:5821–5825

    Google Scholar 

  48. Uchiumi T, Kohno K, Tanimura H, Hidaka K, Asakuno K, Abe H, Uchida Y, Kuwano M (1993) Involvement of protein kinase in environmental stress-induced activation of human multidrug resistance 1 (MDR1) gene promoter. FEBS Lett 325:11–16

    Google Scholar 

  49. Vendrik CPJ, Bergers JJ, De Jong WH, Steerenberg PA (1992) Resistance to cytostatic drugs at the cellular level. Cancer Chemother Pharmacol 29:413–429

    Google Scholar 

  50. Vojtek AB, Hollenberg SM, Cooper JA (1993) Mammalian ras interacts directly with the serine/threonine kinase raf. Cell 74:205–214

    Google Scholar 

  51. Warne PH, Viciana PR, Downward J (1993) Direct interaction of ras and the amino-terminal region of raf-1 in vitro. Nature 364:352–355

    Google Scholar 

  52. Yu G, Ahmad S, Aquino A, Fairchild CR, Trepel JB, Ohno S, Susuku K, Tsuruo K, Cowan KH, Glaszer RI (1991) Transfection with protein kinase Cα confers increased multidrug resistance to MCF-7 cells expressing P-glycoprotein. Cancer Commun 3:181–188

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institut für Medizinische Chemie und Biochemie, Universität Innsbruck, Innsbruck, Austria

    H. Grunicke, J. Hofmann, I. Utz & F. überall

Authors
  1. H. Grunicke
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Hofmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. I. Utz
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. F. überall
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

This work was supported by grant P-08545-MCD from the Austrian Science Foundation

Rights and permissions

Reprints and permissions

About this article

Cite this article

Grunicke, H., Hofmann, J., Utz, I. et al. Role of protein kinases in antitumor drug resistance. Ann Hematol 69, S1–S6 (1994). https://doi.org/10.1007/BF01757347

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01757347

Keywords

Search

Navigation